| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1985PNAS...82..584S |
| P356 | DOI | 10.1073/PNAS.82.2.584 |
| P932 | PMC publication ID | 397085 |
| P698 | PubMed publication ID | 3871527 |
| P5875 | ResearchGate publication ID | 19289466 |
| P2093 | author name string | Paillotin G | |
| Aumont MC | |||
| Syrota A | |||
| Maziere B | |||
| Comar D | |||
| Davy JM | |||
| Stulzaft O | |||
| P2860 | cites work | Cardiac muscarinic cholinergic receptor binding is regulated by Na+ and guanyl nucleotides | Q71138059 |
| Muscarinic receptor binding in mouse brain: regulation by guanine nucleotides | Q71259102 | ||
| In vivo quantitation of regional myocardial blood flow by positron-emission computed tomography | Q72088371 | ||
| In vivo characterization of myocardium muscarinic receptors by positron emission tomography | Q72100804 | ||
| Regional blood flow by fractional distribution of indicators | Q74847408 | ||
| Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide | Q36286430 | ||
| Properties of muscarinic acetylcholine receptors in heart cell cultures | Q37595690 | ||
| Parasympathetic control of the heart. | Q39897490 | ||
| Quantitative aspects of hormone-receptor interactions of high affinity. Effect of receptor concentration and measurement of dissociation constants of labeled and unlabeled hormones | Q39961137 | ||
| Mechanisms of slow postsynaptic potentials | Q40084404 | ||
| Neural regulation of the heart beat | Q40302509 | ||
| The acetylcholine receptor: an "allosteric" membrane protein | Q41209431 | ||
| Isomerization of the muscarinic receptor . antagonist complex | Q41629373 | ||
| Guanine nucleotides modulate muscarinic receptor binding in the heart | Q41723535 | ||
| Cardiac muscarinic cholinergic receptors. Biochemical identification and characterization | Q43610821 | ||
| The binding of agonists to brain muscarinic receptors | Q48162424 | ||
| Kinetics of in vivo binding of antagonist to muscarinic cholinergic receptor in the human heart studied by positron emission tomography | Q52689644 | ||
| Rapid kinetics of agonist binding and permeability response analyzed in parallel on acetylcholine receptor rich membranes from Torpedo marmorata. | Q52700229 | ||
| In vivo regulation of muscarinic acetylcholine receptor number and function in embryonic chick heart | Q52735154 | ||
| The distribution of the muscarinic acetylcholine receptor antagonists, quinuclidinyl benzilate and quinuclidinyl benzilate methiodide (both tritiated), in rat, guinea pig, and rabbit | Q53970746 | ||
| Regional and subcellular distribution of myocardial muscarinic cholinergic receptors. | Q53978032 | ||
| Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerization | Q66946823 | ||
| Muscarinic acetylcholine receptors in developing chick heart | Q67013891 | ||
| Enrichment, solubilization, and partial characterization of digitonin-solubilized muscarinic receptors derived from canine ventricular myocardium | Q67302415 | ||
| Criteria for receptor sites in binding studies | Q70200403 | ||
| The biphasic response of muscarinic cholinergic receptors in cultured heart cells to agonists. Effects on receptor number and affinity in intact cells and homogenates | Q70429578 | ||
| P4510 | describes a project that uses | positron emission tomography | Q208376 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 584-588 | |
| P577 | publication date | 1985-01-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Muscarinic cholinergic receptor in the human heart evidenced under physiological conditions by positron emission tomography | |
| P478 | volume | 82 |
| Q38062361 | Assessment of cardiac autonomic neuronal function using PET imaging |
| Q68136332 | Baroreflex control of stroke volume in man: an effect mediated by the vagus |
| Q88039803 | Cardiac molecular imaging to track left ventricular remodeling in heart failure |
| Q34273052 | Cardiac receptor physiology and its application to clinical imaging: present and future |
| Q36811189 | Cardiac sympathetic neuronal imaging using PET. |
| Q40457662 | Cholinergic neurotransmission studied in vivo using positron emission tomography or single photon emission computerized tomography |
| Q36448292 | Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission |
| Q42920670 | Demonstration of the suitability of CGP 12177 for in vivo studies of beta-adrenoceptors |
| Q68006941 | Effects of atropine treatment on in vitro and in vivo binding of 4-[125I]-dexetimide to central and myocardial muscarinic receptors |
| Q68807462 | Features of positron emission tomography as a probe for myocardial chemistry |
| Q36416515 | Imaging cardiac neuronal function and dysfunction |
| Q36267057 | Imaging of metabolism and autonomic innervation of the heart by positron emission tomography. |
| Q57759037 | Iodine-123N- methyl-4-iododexetimide: a new radioligand for single-photon emission tomographic imaging of myocardial muscarinic receptors |
| Q48628005 | Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET. |
| Q48361745 | Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy |
| Q42621815 | Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches. |
| Q72100840 | Myocardial accumulation of a dopamine D2 receptorbinding radioligand, 2′-iodospiperone |
| Q38123474 | Myths and realities of the cardiac vagus |
| Q38016654 | Positron emission tomography and cholinergic mechanisms: an overview |
| Q36503237 | Positron emission tomography studies of brain receptors |
| Q52880636 | Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol. |
| Q38397104 | Radionuclide imaging of neurohormonal system of the heart |
| Q33719875 | Radionuclide imaging probes for expressed proteins |
| Q38028657 | Rebinding: or why drugs may act longer in vivo than expected from their in vitro target residence time |
| Q34431362 | Vagal control of myocardial contractility in humans |
| Q37893938 | Where have we got to with neuroreceptor mapping of the human brain? |
| Q74573700 | [PET radiopharmaceuticals] |
Search more.